Global Intravenous Solutions Market 2016-2020

  • ID: 3736370
  • Report
  • Region: Global
  • 53 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Bioscrip
  • Fresenius Kabi AG
  • Hospira Inc
  • JW Life Science
  • Terumo
  • MORE
About the Intravenous Solutions Market

The infusion of liquid substances, such as nutrients and drugs, directly into a vein is referred as intravenous therapy. Intravenous fluids are extensively used to treat electrolyte imbalances, maintain fluid balance, and replace fluid losses. These fluids are dispensed in volumes ranging from 25-1,000 milliliters and are available in either plastic bags or glass bottles. A complete mixture of all essential nutrients is also available in multi-chamber bags, and these bags are gaining immense popularity among numerous end-users.

The analysts forecast the global intravenous solutions market to grow at a CAGR of 5.79% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous solutions market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of various type intravenous fluids:
- Crystalloids
- Colloids
- Free H2O solutions

The market is divided into the following segments based on geography:
- Americas
- APAC
- Europe
- MEA

The report, Global Intravenous Solutions Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Baxter
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Hospira Inc.

Other prominent vendors
- Bioscrip
- Claris Lifesciences
- Grifols
- IV Solutions
- JW Life Science
- Sichuan Kelun Pharmaceutical
- Terumo
- Thai Otsuka Pharmaceutical
- Omnicare
- Vifor Pharma
- Widatra Bhakti

Market drivers
- Rise in health problems
- For a full, detailed list, view the full report

Market challenges
- Stringent government regulations
- For a full, detailed list, view the full report

Market trends
- Growing popularity of intravenous vitamin C therapy in cancer treatment
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Bioscrip
  • Fresenius Kabi AG
  • Hospira Inc
  • JW Life Science
  • Terumo
  • MORE
PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Five forces analysis
PART 06: Geographical segmentation
  • Global intravenous solutions market by geography
  • Intravenous solutions market in Americas
  • Intravenous solutions market in Europe
  • Intravenous solutions market in APAC
  • Intravenous solutions market in MEA
PART 07: Key leading countries

PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape
  • Competitive scenario
PART 14: Key vendor analysis
  • Key vendor analysis
  • Baxter
  • B. Braun Melsungen
  • Fresenius Kabi
  • Hospira
  • Other prominent vendors
  • Bioscrip
  • Claris Lifesciences
  • Grifols
  • JW Life Science
  • Sichuan Kelun Pharmaceutical
  • Terumo
  • Omnicare
  • Vifor Pharma
  • Widatra Bhakti
PART 15: Appendix
  • List of abbreviations
PART 16: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global intravenous solutions market 2015-2020 ($ billions)
Exhibit 03: Global intravenous solutions market by geography 2015-2020 ($ billions)
Exhibit 04: Global intravenous solutions market by geography 2015-2020
Exhibit 05: Intravenous solutions market in Americas 2015-2020 ($ billions)
Exhibit 06: Intravenous solutions market in Europe 2015-2020 ($ billions)
Exhibit 07: Intravenous solutions market in APAC 2015-2020 ($ millions)
Exhibit 08: Intravenous solutions market in MEA 2015-2020 ($ millions)
Exhibit 09: Global intravenous solutions market growth by geography 2015-2020 ($ billions)
Exhibit 10: CAGR comparison of various regions of global intravenous solutions market 2016-2020
Exhibit 11: Intravenous solutions market in US 2015-2020 ($ billions)
Exhibit 12: Intravenous solutions market in Germany 2015-2020 ($ millions)
Exhibit 13: Intravenous solutions market in UK 2015-2020 ($ millions)
Exhibit 14: Impact of drivers
Exhibit 15: Impact of drivers and challenges
Exhibit 16: Business segmentation
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Bioscrip
  • Fresenius Kabi AG
  • Hospira Inc
  • JW Life Science
  • Terumo
  • MORE
New Report Released: – Global Intravenous Solutions Market 2016-2020

The author of the report recognizes the following companies as the key players in the Global Intravenous Solutions Market: Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, and Hospira Inc.

Other Prominent Vendors in the market are: Bioscrip, Claris Lifesciences, Grifols, IV Solutions, JW Life Science, Sichuan Kelun Pharmaceutical, Terumo, Thai Otsuka Pharmaceutical, Omnicare, Vifor Pharma, and Widatra Bhakti.

Commenting on the report, an analyst from the research team said: “The rising popularity of intravenous vitamin C therapy in cancer treatment is one of the major trends in the market. The intravenous vitamin C solution has been observed to have an increased toxicity to cancer cells and improve the patients' quality of life.”

According to the report, the growth of the global intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that is expected to increase the rate of adoption of intravenous solutions among consumers.

Further, the report states that the presence of stringent regulations introduced by governments leads to unnecessary delays and additional costs in manufacturing. This hinders the growth of the vendors and, therefore, the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
- B. Braun Melsungen AG
- Baxter
- Bioscrip
- Claris Lifesciences
- Fresenius Kabi AG
- Grifols
- Hospira Inc
- IV Solutions
- JW Life Science
- Omnicare
- Sichuan Kelun Pharmaceutical
- Terumo
- Thai Otsuka Pharmaceutical
- Vifor Pharma
- Widatra Bhakti

Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll